All Podcasts – Johns Hopkins Medicine Podcasts

Sleep difficulties or insomnia are common, and the problem is growing. The latest data reveals that about a third of us have the condition, with women affected more often than men. Psychiatrist Andrew Huhn at Johns Hopkins says to address …

Can your sleep patterns be making you sick? Elizabeth Tracey reports Read More »

Something called the blood brain barrier prevents many things, including most drugs, from entering your brain. Now a new study that disrupts the barrier using ultrasound seems to have shown that antibodies to treat Alzheimer’s disease can gain entry this …

Can a novel way to get antibodies into the brain help Alzheimer’s disease? Elizabeth Tracey reports Read More »

Monoclonal antibodies for Alzheimer’s disease, like the drug called Aduhelm, attach to aberrant proteins thought to be one cause of the disease, but they only stand to benefit a small number of the people who might be at risk. That’s …

Only a small percentage of people are candidates for monoclonal antibodies to treat Alzheimer’s disease, Elizabeth Tracey reports Read More »

Aduhelm is a type of drug called a monoclonal antibody, and it’s used to remove some of the aberrant proteins thought to cause Alzheimer’s disease. Lolita Nidadavolu, a geriatrics expert at Johns Hopkins, says there is much to consider when …

Who is a candidate for monoclonal antibodies for Alzheimer’s disease? Elizabeth Tracey reports Read More »

Men who reported taking sildenafil for erectile dysfunction also had a reduced risk for Alzheimer’s disease, a recent study looking at a large number of medical records found. What about women? Johns Hopkins geriatrics expert Lolita Nidadavolu, who wrote an …

Should women use sildenafil to reduce their risk of Alzheimer’s disease? Elizabeth Tracey reports Read More »

Sildenafil, taken for erectile dysfunction, seems to have helped reduce Alzheimer’s disease risk in men. Would the drug have the same impact on women, and what might the side effects look like? Lolita Nidadavolu, a geriatrics expert at Johns Hopkins …

Would sildenafil work to reduce Alzheimer’s disease risk in women? Elizabeth Tracey reports Read More »

Taking sildenafil for erectile dysfunction reduced the risk for developing Alzheimer’s disease, a study looking at medical records of over 260,000 found.  Geriatrics expert Lolita Nidadavolu at Johns Hopkins and coauthor of an editorial on the study says there is a …

How might sildenafil work to reduce Alzheimer’s risk? Elizabeth Tracey reports Read More »

Men who took sildenafil for erectile dysfunction experienced less Alzheimer’s disease than men who did not, a very large study looking at medical records found. One problem, says Lolita Nidadavolu, a Johns Hopkins geriatrics expert and coauthor of an editorial …

How often does sildenafil need to be taken to reduce the risk of Alzheimer’s disease? Elizabeth Tracey reports Read More »

Sildenafil is used by men with erectile dysfunction, with a recent study examining medical records of men who used it finding they also developed Alzheimer’s disease less often. This is called an observational study, and it only can find an …

The erectile dysfunction drug sildenafil may reduce the risk of Alzheimer’s disease, Elizabeth Tracey reports Read More »

Examining the medical records of more than 265,000 men has revealed that those who took the erectile dysfunction drug sildenafil experienced a reduced rate of Alzheimer’s disease in comparison to those who did not. Lolita Nidadavolu, a geriatrics expert at …

Can the erectile dysfunction drug sildenafil help stave off Alzheimer’s disease? Elizabeth Tracey reports Read More »